KNOWLEDGE ATTITUDE AND PRACTICE OF CERVICAL CANCER SCREENING AND VACCINATION AMONG WOMEN IN GWAGWALADA AREA COUNCIL, ABUJA NIGERIA
DOI:
https://doi.org/10.61841/t585zc72Keywords:
Cervical cancer screening, HPV vaccination uptake, Knowledge, Attitudes, PracticeAbstract
Background: Cervical cancer remains one of the leading causes of cancer morbidity and mortality among women in low- and middle-income countries, despite being largely preventable through screening and vaccination against human papillomavirus (HPV). Knowledge, attitude, and practice (KAP) studies provide valuable insights for designing effective preventive interventions. This study assessed the KAP of cervical cancer screening and HPV vaccination among women in Gwagwalada Area Council, Abuja, Nigeria.
Methods: A descriptive cross-sectional survey was conducted among 244 women aged 15–49 years. The participants were recruited through systematic random and cluster sampling. Data were collected using structured interviewer-administered and self-administered questionnaires. Statistical analysis was performed using SPSS version 21. Associations between socio-demographic characteristics, knowledge, attitude, and vaccination practice were evaluated using chi-square tests at a significance level of p < 0.05.
Results: More than half of the participants (54.5%) demonstrated good knowledge of HPV vaccination, while 45.5% had poor knowledge. Despite this high knowledge, uptake of HPV vaccination was very low (6.1%). Vaccination was highest among students (10.3%) and women with secondary education (11.1%). Knowledge (p = 0.041) and positive attitude (p = 0.018) were significantly associated with vaccination uptake. However, socio-demographic variables such as age and marital status were not significantly associated.
Conclusion: The study revealed a wide gap between knowledge and practice of cervical cancer prevention in the study population. While awareness of HPV vaccination was relatively high, uptake was alarmingly low. Positive attitudes were strongly linked to vaccination practice, highlighting the need for interventions that address both structural and behavioral barriers.
References
Abdullahi, A., Copping, J., Kessel, A., Luck, M., & Bonell, C. (2009). Cervical screening: Perceptions and barriers to uptake among Somali women in Camden. Public Health, 123(10), 680–685. https://doi.org/10.1016/j.puhe.2009.09.011
Asogun, D., Alenoghena, I., & Egbefere, H. (2024). Knowledge, attitude and practice of cervical cancer screening among reproductive age group women in Ekpoma, South-South Nigeria. The Nigerian Health Journal, 24(3), 1566–1576. https://doi.org/10.60787/tnhj.v24i3.881
Binagwaho, A., Wagner, C. M., Gatera, M., Karema, C., Nutt, C. T., & Ngabo, F. (2012). Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme. Bulletin of the World Health Organization, 90(8), 623–628. https://doi.org/10.2471/BLT.11.097253
Bosch, F. X., & de Sanjosé, S. (2002). Human papillomavirus in cervical cancer. Current Oncology Reports, 4(2), 175–184. https://doi.org/10.1007/s11912-002-0020-3
Bosch, F. X., & Muñoz, N. (2002). The viral etiology of cervical cancer. Virus Research, 89(2), 183–190. https://doi.org/10.1016/S0168-1702(02)00187-9
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013). Human papillomavirus and cervical cancer. The Lancet, 382(9895), 889–899. https://doi.org/10.1016/S0140-6736(13)60022-7
Cunningham, M. S., Skrastins, E., Fitzpatrick, R., Jindal, P., Oneko, O., Yeates, K., & Ginsburg, O. (2015). Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania. BMJ Open, 5(3), e005828. https://doi.org/10.1136/bmjopen-2014-005828
Cutts, F. T., Franceschi, S., Goldie, S., Castellsagué, X., de Sanjosé, S., & Garnett, G. (2007). Human papillomavirus and HPV vaccines: A review. Bulletin of the World Health Organization, 85(9), 719–726. https://doi.org/10.2471/BLT.06.038414
Ebu, N. I., Mupepi, S. C., Siakwa, M. P., & Sampselle, C. M. (2014). Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern Ghana. International Journal of Women’s Health, 7, 31–39. https://doi.org/10.2147/IJWH.S71797
Elkharashy, S. M., Mohammed, N. G. R., & Yasser, H. (2013). Prevalence of high-risk human papillomavirus types 16/18 in cytologically abnormal cervical smears in Alexandria, Egypt: A cytological and molecular study. Middle East Fertility Society Journal, 18(4), 253–267. https://doi.org/10.1016/j.mefs.2013.03.004
International Agency for Research on Cancer (IARC), & World Health Organization. (2013). Latest world cancer statistics: Global cancer burden rises to 14.1 million cases in 2012 – Marked increase in breast cancers must be addressed [Press release]. https://www.iarc.who.int/news-events/latest-world-cancer-statistics-global-cancer-burden-rises-to-14-1-million-cases-in-2012
Kaspersen, M. D., Larsen, P. B., Ingerslev, H. J., Fedder, J., & Bonde, J. (2011). Identification of multiple HPV types on spermatozoa from human sperm donors. PLOS ONE, 6(3), e18095. https://doi.org/10.1371/journal.pone.0018095
Kumar, V., Abbas, A. K., Fausto, N., & Mitchell, R. N. (2007). Robbins basic pathology (8th ed.). Elsevier Saunders.
Musa, J., Achenbach, C. J., O’Dwyer, L. C., Evans, C. T., McHugh, M., Hou, L., & Simon, M. A. (2017). Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis. PLOS ONE, 12(9), e0183924. https://doi.org/10.1371/journal.pone.0183924
Mutyaba, T., Mmiro, F. A., & Weiderpass, E. (2006). Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda. BMC Medical Education, 6, 13. https://doi.org/10.1186/1472-6920-6-13
Odetola, T. D. (2011). Knowledge, attitude and utilization of cervical cancer screening among women in Ibadan, Nigeria. African Journal of Reproductive Health, 15(4), 47–52.
Schiffman, M., & Wentzensen, N. (2010). From human papillomavirus to cervical cancer. Obstetrics & Gynecology, 116(1), 177–185. https://doi.org/10.1097/AOG.0b013e3181e4629f
Zeferino, L. C., Rabelo-Santos, S. H., Villa, L. L., & Syrjänen, K. J. (2011). Value of HPV-DNA testing in women with cytological diagnosis of atypical glandular cells (AGC). European Journal of Obstetrics & Gynecology and Reproductive Biology, 159(1), 160–164. https://doi.org/10.1016/j.ejogrb.2011.07.009
Downloads
Published
Data Availability Statement
The given research data in the submission is available and accessible to all readers
Issue
Section
License
Copyright (c) 2025 Ochem Michael Uzorchukwu, Abu Agbokhade Gift, Akata Grace Amarachi, Okpechukwu Chidubem Peter, Muhammed Khaleed, Shuaib Usman Karuma, Efe Okorare, Dennis Kure Yusuf, Chibueze Mercy Asabe, Gandu T.Y. Purity, Ummulkhair Muhammad (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
